Articles

  • 1 month ago | endocrinologyadvisor.com | Ellen Strenger |Jayne Feld

    Pulmonologists have achieved miraculous results in helping patients with acute breathing problems — such as pneumonia, asthma exacerbations, and emphysema — to breathe again, says journalist James Nestor. Yet the medical world has a blind spot when it comes to one key aspect of breathing: the importance of how we breathe.

  • 1 month ago | pulmonologyadvisor.com | Ellen Strenger |Jayne Feld

    Pulmonologists have achieved miraculous results in helping patients with acute breathing problems — such as pneumonia, asthma exacerbations, and emphysema — to breathe again, says journalist James Nestor. Yet the medical world has a blind spot when it comes to one important aspect breathing: the importance of how we breathe.

  • Jan 24, 2025 | pulmonologyadvisor.com | Ellen Strenger

    In December and January, the US Food and Drug Administration (FDA) approved new therapies for lung cancer, atopic dermatitis, obstructive sleep apnea (OSA), and cystic fibrosis. The FDA also added a warning regarding Guillain-Barré Syndrome to respiratory syncytial virus (RSV) vaccines’ prescribing information.

  • Nov 22, 2024 | pulmonologyadvisor.com | Colby Stong |Ellen Strenger

    The Global Initiative for Chronic Obstructive Lung Disease (GOLD) released its 2025 updated version of the GOLD Chronic Obstructive Pulmonary Disease (COPD) report earlier this month, just in time for World COPD Day on November 20.

  • Sep 20, 2024 | pulmonologyadvisor.com | Ellen Strenger

    Over the summer, the US Food and Drug Administration (FDA) approved an adult respiratory syncytial virus (RSV) vaccine and a pneumococcal 21-valent conjugate vaccine. The agency also issued updates and recalls for a number of medical devices used in critical care delivery.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →